Cappello Joseph - Insider Non-Derivative Transactions at GENELUX CORP (GNLX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 14, 2024, Cappello Joseph's relationship to GENELUX CORP (GNLX) is Officer (VP, Pharmaceutical Development), and currently has 20,953 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other GNLX insiders.

Data Source: SEC.
Cappello Joseph - Insider Non-Derivative Transactions of GNLX Common Stock
Cappello Joseph - Insider Non-Derivative Transactions at GNLX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 15, 2024 Acquisition -- (Common Stock) 11557 0 20953
Feb 20, 2024 Acquisition -- (Common Stock) 3661 0 9396
Aug 19, 2023 Sell -- (Common Stock) 3265 23.73 5735
Feb 18, 2023 Acquisition -- (Common Stock) 9000 0 9000